Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Synflorix I Group	178
Overall Study	STARTED	Synflorix II Group	27
Overall Study	STARTED	Synflorix PRE Group	172
Overall Study	STARTED	Synflorix POST Group	37
Overall Study	STARTED	Mencevax + Infanrix Hexa Group	336
Overall Study	COMPLETED	Synflorix I Group	177
Overall Study	COMPLETED	Synflorix II Group	27
Overall Study	COMPLETED	Synflorix PRE Group	172
Overall Study	COMPLETED	Synflorix POST Group	36
Overall Study	COMPLETED	Mencevax + Infanrix Hexa Group	336
Overall Study	NOT COMPLETED	Synflorix I Group	1
Overall Study	NOT COMPLETED	Synflorix II Group	0
Overall Study	NOT COMPLETED	Synflorix PRE Group	0
Overall Study	NOT COMPLETED	Synflorix POST Group	1
Overall Study	NOT COMPLETED	Mencevax + Infanrix Hexa Group	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00496015/flow